Mona Ranade, MD
Interventional Radiology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 1 carrier
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
12 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Ranade’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A170242 · Current
Licensed to practise in California · since 2020 · expires 2028-09-30 · University of Wisconsin Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$67,107
Medicare paid this office $67,107 for 241 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Insertion of tunneled central venous tube for infusion (5 years or older) | 18 | $3,795 | $200 |
| Ultrasound of both sides of head and neck blood flow | 19 | $2,879 | $152 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 16 | $2,643 | $165 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 12 | $1,223 | $102 |
| Ultrasonic guidance for blood vessel access | 54 | $827 | $11 |
See all 8 services
| Insertion of tunneled central venous tube for infusion (5 years or older) | 18 | $3,795 | $200 |
| Ultrasound of both sides of head and neck blood flow | 19 | $2,879 | $152 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 16 | $2,643 | $165 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 12 | $1,223 | $102 |
| Ultrasonic guidance for blood vessel access | 54 | $827 | $11 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 77 | $785 | $10 |
| Review by radiologist of ct guidance for needle placement | 13 | $737 | $57 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 26 | $419 | $14 |
Procedures Medicare counted
| Varicose vein removal | 1-10 | None |
Who their Medicare patients are
241 Original Medicare patients in 2024. Average age 72 · Under 65 18% · 85 and older 11% · Women 49% · Also on Medicaid 41% · Health risk score 3.65. Sicker patients than 9 in 10 peers; the typical interventional radiology clinician is at 2.27.
Conditions among them: High blood pressure 75% · Chronic kidney disease 48% · Diabetes 47% · Coronary heart disease 45% · Heart failure 36% · Cancer 33% · Atrial fibrillation 32% · Depression 32% · COPD 25% · Stroke 21% · Dementia 15%.
The office billed $2,455,920, Medicare allowed $85,195 and paid $67,107; for 682 services of 132 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 241 | 682 | 72 | 3.65 | $2,455,920 | $67,107 |
| 2023 | 348 | 1,407 | 73 | 3.17 | $2,316,483 | $124,010 |
| 2022 | 343 | 1,495 | 71 | 2.62 | $2,130,454 | $128,913 |
| 2021 | 333 | 1,503 | 72 | 2.97 | $2,425,387 | $146,248 |
| 2020 | 217 | 1,140 | 72 | 3.68 | $1,015,752 | $55,490 |
| 2019 | 620 | 2,872 | 72 | 3.35 | $1,603,093 | $77,676 |
| 2018 | 534 | 4,066 | 71 | 3.35 | $2,659,768 | $118,904 |
| 2017 | 164 | 1,004 | 71 | 3.50 | $877,987 | $45,574 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 14 services
| Insertion of central venous tube with port (5 years or older) | 21 | $18,624 | $887 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 58 | $9,416 | $160 |
| Ultrasound of both sides of head and neck blood flow | 27 | $4,651 | $172 |
| Ultrasound of leg arteries or artery grafts | 15 | $3,197 | $213 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 30 | $3,191 | $106 |
| Insertion of tunneled central venous tube for infusion (5 years or older) | 13 | $2,703 | $208 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 51 | $2,521 | $45 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 26 | $2,371 | $91 |
| Biopsy and aspiration of bone marrow sample for diagnosis | 15 | $2,315 | $154 |
| Review by radiologist of ct guidance for needle placement | 17 | $2,193 | $129 |
| Ultrasonic guidance for blood vessel access | 26 | $978 | $36 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 53 | $563 | $10 |
| Ultrasonic guidance for blood vessel access | 43 | $545 | $12 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 26 | $377 | $14 |
2022: 14 services
| Insertion of central venous tube with port (5 years or older) | 23 | $21,131 | $919 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 48 | $8,286 | $173 |
| Insertion of tunneled central venous tube for infusion (5 years or older) | 21 | $4,448 | $212 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 36 | $3,869 | $107 |
| Ultrasound of both sides of head and neck blood flow | 20 | $3,461 | $173 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 50 | $2,421 | $47 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 23 | $2,342 | $94 |
| Biopsy and aspiration of bone marrow sample for diagnosis | 11 | $1,790 | $163 |
| Review by radiologist of ct guidance for needle placement | 13 | $1,702 | $131 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 53 | $607 | $11 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 33 | $549 | $16 |
| Ultrasonic guidance for blood vessel access | 38 | $548 | $12 |
| Ultrasonic guidance for blood vessel access | 14 | $509 | $36 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 11 | $65 | $0 |
2021: 15 services
| Insertion of central venous tube with port (5 years or older) | 16 | $15,972 | $998 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 31 | $5,676 | $183 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 35 | $4,012 | $115 |
| Ultrasound of both sides of head and neck blood flow | 17 | $3,207 | $189 |
| Review by radiologist of ct guidance for needle placement | 23 | $3,165 | $138 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 64 | $3,096 | $48 |
| Removal of central venous tube with port or pump | 11 | $2,207 | $201 |
| Biopsy and aspiration of bone marrow sample for diagnosis | 11 | $1,833 | $167 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 17 | $1,671 | $98 |
| Short return visit (20+ min) | 11 | $1,071 | $82 |
| Insertion of tube into vena cava | 12 | $797 | $53 |
| Ultrasonic guidance for blood vessel access | 41 | $648 | $12 |
| Ultrasonic guidance for blood vessel access | 15 | $576 | $36 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 51 | $575 | $11 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 16 | $258 | $16 |
2020: 8 services
| Review by radiologist of ct guidance for needle placement | 11 | $1,535 | $140 |
| Ct scan of blood vessels of abdomen and pelvis with contrast | 11 | $1,156 | $96 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 18 | $867 | $48 |
| Review by radiologist of ct guidance for needle placement | 11 | $758 | $69 |
| X-ray of chest, 1 view | 53 | $677 | $8 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 46 | $555 | $11 |
| Ultrasonic guidance for blood vessel access | 29 | $419 | $13 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 21 | $352 | $17 |
2019: 16 services
| Occlusion of growths or obstructed vessels with review by radiologist | 13 | $7,768 | $518 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 19 | $4,568 | $176 |
| X-ray of chest, 1 view | 369 | $4,138 | $8 |
| Placement of tube of kidney using imaging guidance with review by radiologist | 11 | $2,306 | $210 |
| Ct scan of blood vessels of abdomen and pelvis with contrast | 18 | $1,746 | $97 |
| New patient visit (15+ min) | 24 | $1,614 | $67 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 14 | $1,271 | $91 |
| New patient visit (30+ min) | 12 | $1,179 | $98 |
| Short return visit (20+ min) | 15 | $1,140 | $67 |
| Ultrasonic guidance for blood vessel access | 50 | $776 | $13 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 53 | $669 | $11 |
| 3d radiographic procedure with computerized image postprocessing | 11 | $461 | $35 |
| X-ray of chest, 2 views | 44 | $435 | $9 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 17 | $286 | $17 |
| X-ray of abdomen, 1 view | 21 | $171 | $8 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 21 | $147 | $0 |
2018: 21 services
| Occlusion of growths or obstructed vessels with review by radiologist | 19 | $14,454 | $516 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 26 | $8,819 | $173 |
| Ct scan of blood vessels of abdomen and pelvis with contrast | 17 | $5,518 | $325 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 46 | $4,276 | $91 |
| Ct scan of blood vessels of abdomen and pelvis with contrast | 29 | $3,003 | $97 |
| X-ray of chest, 1 view | 235 | $2,455 | $8 |
| Insertion of tube into abdominal, pelvic, or leg artery, each first order branch | 15 | $2,348 | $130 |
| Insertion of tube into abdominal, pelvic, or leg artery, additional second, third, and beyond | 15 | $1,758 | $45 |
| Ct scan of blood vessels of chest with contrast | 16 | $1,363 | $76 |
| Ultrasonic guidance for blood vessel access | 64 | $1,170 | $13 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 75 | $1,132 | $12 |
| Review by radiologist of abdominal artery image | 12 | $1,081 | $49 |
| 3d radiographic procedure with computerized image postprocessing | 18 | $1,063 | $35 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 19 | $866 | $46 |
| New patient visit (15+ min) | 12 | $751 | $63 |
| Review by radiologist of ct guidance for needle placement | 13 | $673 | $52 |
| X-ray of chest, 2 views | 38 | $376 | $10 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 18 | $302 | $17 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 16 | $293 | $10 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 35 | $254 | $0 |
| X-ray of abdomen, 1 view | 22 | $179 | $8 |
2017: 11 services
| Occlusion of growths or obstructed vessels with review by radiologist | 12 | $6,829 | $525 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 14 | $3,221 | $161 |
| Ct scan of blood vessels of abdomen and pelvis with contrast | 21 | $2,047 | $97 |
| New patient visit (15+ min) | 11 | $744 | $68 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $703 | $64 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 11 | $521 | $47 |
| Ultrasonic guidance for blood vessel access | 27 | $411 | $13 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 26 | $331 | $11 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 14 | $255 | $17 |
| X-ray of chest, 1 view, front | 27 | $235 | $8 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 11 | $57 | $0 |
Medicaid work
$332 in 2020
Medicaid paid $332 for 64 billed services this clinician did in 2020, up to 27 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Radiologic examination, chest; single view | 64 | $332 |
| 2020 | 64 | 1 | 27 | $332 |
| 2019 | 251 | 2 | 34 | $1,505 |
| 2018 | 34 | 1 | 17 | $332 |
See the largest Medicaid services in earlier years
2019
| Radiologic examination, chest; single view | 239 | $1,371 |
| Radiologic examination, chest; 2 views | 12 | $134 |
2018
| Radiologic examination, chest; single view | 34 | $332 |
Money from drug and device companies
$29,952 in 2025
| 2025 | 12 | 51 | $24,188 | $29,952 |
| 2024 | 11 | 51 | $16,006 | $20,352 |
| 2023 | 12 | 34 | $4,238 | $9,516 |
| 2022 | 14 | 117 | $9,450 | $36,775 |
| 2021 | 12 | 46 | None | $3,029 |
| 2020 | 3 | 6 | None | $276 |
| 2019 | 5 | 13 | $900 | $1,606 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Stryker | Ct Thrombectomy System Kit | $12,449 | 6 payments
|
| Medtronic | Abre | $10,931 | 22 payments
|
| Penumbra | Ruby Coil | $4,153 | 4 payments
|
| Endovascular Engineering | Helo Thrombectomy System | $1,000 | 2 payments
|
| Boston Scientific | Jetstream Sc | $380 | 3 payments
|
| W. L. Gore & Associates | Gore Viabahn Endoprosthesis | $305 | 3 payments
|
See all 51 published payments
| Medtronic | Consulting · 2025-12-19 | None | $6,938 |
| W. L. Gore & Associates | Meals · 2025-12-05 | Gore Viatorr Tips Endoprosthesis With Controlled Expansion | $17 |
| Medtronic | Meals · 2025-12-03 | Abre | $73 |
| Medtronic | Travel · 2025-12-03 | None | $162 |
| Medtronic | Travel · 2025-12-02 | None | $161 |
| Medtronic | Travel · 2025-12-02 | None | $24 |
| Medtronic | Meals · 2025-12-02 | Abre | $1 |
| Medtronic | Meals · 2025-12-02 | Abre | $24 |
| Medtronic | Travel · 2025-12-02 | None | $94 |
| Medtronic | Meals · 2025-11-25 | Abre | $11 |
| W. L. Gore & Associates | Meals · 2025-11-25 | Gore Viabahn Endoprosthesis | $272 |
| Boston Scientific | Meals · 2025-11-20 | General - Vascular Intervention | $59 |
| Medtronic | Travel · 2025-11-19 | None | $20 |
| Medtronic | Travel · 2025-11-19 | None | $10 |
| Medtronic | Travel · 2025-11-18 | None | $10 |
| Medtronic | Meals · 2025-11-14 | Synchromedii | $151 |
| Medtronic | Travel · 2025-11-14 | Synchromedii | $269 |
| Medtronic | Travel · 2025-11-14 | Synchromedii | $49 |
| Penumbra | Paid to speak or teach · 2025-11-13 | Ruby Coil | $4,000 |
| Medtronic | Travel · 2025-11-13 | None | $740 |
| Endovascular Engineering | Honoraria · 2025-11-10 | Helo Thrombectomy System | $500 |
| W. L. Gore & Associates | Meals · 2025-11-06 | Gore Viatorr Tips Endoprosthesis With Controlled Expansion | $16 |
| Medtronic | Paid to speak or teach · 2025-10-17 | Abre | $1,375 |
| Siemens Medical Solutions USA | Meals · 2025-10-11 | Artis Icono Floor | $68 |
| Stryker | Consulting · 2025-10-09 | Ct Thrombectomy System Kit | $9,750 |
| Stryker | Consulting · 2025-10-09 | Ct Thrombectomy System Kit | $650 |
| Penumbra | Meals · 2025-09-26 | Indigo System | $136 |
| Boston Scientific | Meals · 2025-09-19 | Ekosonic | $150 |
| AngioDynamics | Meals · 2025-09-19 | Alphavac | $27 |
| Medtronic | Meals · 2025-09-18 | None | $17 |
| Endovascular Engineering | Honoraria · 2025-09-17 | Helo Thrombectomy System | $500 |
| Stryker | Travel · 2025-09-05 | Clottriever Bold Catheter | $1,771 |
| Stryker | Meals · 2025-08-29 | Flowtriever | $24 |
| Medtronic | Meals · 2025-08-05 | Emprint | $176 |
| Medtronic | Meals · 2025-08-03 | Emprint | $25 |
| Penumbra | Travel · 2025-07-23 | Indigo System | $8 |
| Penumbra | Travel · 2025-07-14 | Indigo System | $10 |
| Boston Scientific | Meals · 2025-06-10 | Jetstream Sc | $172 |
| AngioDynamics | Meals · 2025-06-07 | Alphavac | $80 |
| Medtronic | Meals · 2025-06-06 | Intellis Adaptivestim | $125 |
| Cook Medical | Meals · 2025-06-05 | Zilver Vena | $15 |
| Stryker | Meals · 2025-06-05 | Flowtriever Catheter, S | $63 |
| Sirtex Medical | Meals · 2025-05-20 | Sir-Spheres Microspheres | $25 |
| Medtronic | Consulting · 2025-04-11 | None | $475 |
| Siemens Medical Solutions USA | Meals · 2025-03-29 | Artis Icono Floor | $31 |
| Stryker | Meals · 2025-03-27 | Flowtriever Catheter, S | $192 |
| Sirtex Medical | Meals · 2025-03-11 | Sir-Spheres Microspheres | $54 |
| Cagent Vascular | Meals · 2025-02-24 | Serrantor | $185 |
| Inquis Medical | Meals · 2025-02-12 | Aventus | $47 |
| Inquis Medical | Meals · 2025-02-11 | Aventus | $101 |
| Inquis Medical | Meals · 2025-02-11 | Aventus | $101 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $20,352
| Medtronic | Abre | $8,851 | 13 payments
|
| Boston Scientific | Ekosonic | $6,979 | 14 payments
|
| AngioDynamics | Angiovac | $3,143 | 11 payments
|
| Inari Medical | Ct Thrombectomy System Kit | $461 | 4 payments
|
| Asahi Intecc USA | Peripheral Vascular | $450 | 1 payment
|
| Thrombolex | Bashir Endovascular Catheter | $144 | 2 payments
|
| Penumbra | Indigo System | $131 | 1 payment
|
| Siemens Medical Solutions USA | Artis Icono Floor | $95 | 2 payments
|
| Balt USA | Prestige Coil System | $47 | 1 payment
|
| Philips North America | (9556) Ivc Filter Removal | $34 | 1 payment
|
| Argon Medical Devices | Clot Management | $18 | 1 payment
|
2023: $9,516
| AngioDynamics | Alphavac | $4,415 | 10 payments
|
| Boston Scientific | Ekosonic | $2,212 | 9 payments
|
| Medtronic | Abre | $1,322 | 3 payments
|
| Inari Medical | Ct Thrombectomy System Kit | $500 | 1 payment
|
| Terumo Medical | Glidewire | $350 | 1 payment
|
| LimFlow | Limflow System | $330 | 2 payments
|
| Penumbra | Indigo System | $130 | 1 payment
|
| Asahi Intecc USA | Asahi Ptca Guide Wire | $86 | 1 payment
|
| Imperative Care | Symphony Catheter | $50 | 2 payments
|
| Abbott Laboratories | Jeti | $47 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | None | $37 | 1 payment
|
| Sirtex Medical | Sir-Spheres Microspheres | $37 | 1 payment
|
2022: $36,775
| Siemens Medical Solutions USA | Artis Icono Floor | $17,296 | 37 payments
|
| AngioDynamics | Alphavac | $6,634 | 9 payments
|
| Inari Medical | Ct Thrombectomy System Kit | $4,409 | 12 payments
|
| Medtronic | Abre | $3,393 | 18 payments
|
| Penumbra | Indigo System | $2,256 | 9 payments
|
| Boston Scientific | Angiojet Xmi | $1,027 | 8 payments
|
| Philips Electronics North America | (6554) Periph Vasc Undiv | $801 | 8 payments
|
| Terumo Medical | Azur Cx Detachable | $521 | 6 payments
|
| Ethicon US | Neuwave | $161 | 2 payments
|
| HeartFlow | Ffrct | $102 | 2 payments
|
| Sirtex Medical | Sir-Spheres Microspheres | $86 | 1 payment
|
| Truvic Medical | Prodigy Catheter | $39 | 2 payments
|
| Bard Peripheral Vascular | Venovo | $31 | 2 payments
|
| Cook Medical | Zilver Vena | $19 | 1 payment
|
2021: $3,029
| Boston Scientific | General Catheters | $742 | 12 payments
|
| Medtronic | Concerto | $516 | 12 payments
|
| Siemens Medical Solutions USA | Microthermx Microwave Ablation System | $426 | 5 payments
|
| Ethicon US | Neuwave | $353 | 4 payments
|
| HeartFlow | Ffrct | $345 | 3 payments
|
| Inari Medical | Flowtriever Catheter, S | $256 | 3 payments
|
| Terumo Medical | Azur Cx Detachable | $141 | 1 payment
|
| AngioDynamics | Angiovac | $116 | 2 payments
|
| Penumbra | Ruby Coil | $64 | 1 payment
|
| Cook Medical | Zilver Vena | $39 | 1 payment
|
| Abbott Laboratories | Perclose Proglide Suture Mediated Closure System | $17 | 1 payment
|
| Medical Device Business Services | Certus 140 | $15 | 1 payment
|
2020: $276
| Boston Scientific | Angiojet | $141 | 3 payments
|
| Surefire Medical | Precision Infusion System | $115 | 2 payments
|
| Cook Medical | Cook Medical Self-Expanding Stent | $20 | 1 payment
|
2019: $1,606
| Argon Medical Devices | Cleaner | $900 | 2 payments
|
| Siemens Medical Solutions USA | Artis Q | $253 | 3 payments
|
| Boston Scientific | General Metallic Stents | $220 | 4 payments
|
| Terumo Medical | Metacross | $182 | 3 payments
|
| Penumbra | Penumbra Ruby Coil | $51 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| AngioDynamics, Inc. · Evaluating the Safety and Efficacy of the Alphavac Multipurpose Mechanical Aspiration (Mma) F1885 Pe for Treatment of Acute Pulmonary Embolism (Apex-Av) · 2023 | Their institution | $35,381 |
| Penumbra, Inc. · Bolt · 2022 | Their institution | $29,699 |
| Boston Scientific Corporation · Saval Pivotal · 2019 | Their institution | $18,839 |
| Boston Scientific Corporation · Elegance · 2024 | Their institution | $9,000 |
| AngioDynamics, Inc. · Apex · 2024 | Their institution | $8,291 |
| BOSTON SCIENTIFIC CORPORATION · Des Btk · 2020 | Their institution | $6,024 |
| AngioDynamics, Inc. · Apex · 2025 | Their institution | $4,948 |
| ASAHI INTECC USA, INC. · 2023 | This clinician | $1,360 |
| Boston Scientific Corporation · Saval Pivotal · 2021 | Their institution | $389 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 100.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1811296429
- Licence
- CA A170242California A170242: Current · expires 2028-09-30
- Trained
- University of Wisconsin School of Medicine, 2011
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2085R0204X (2085R0204X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2011-03-22
- NPI last updated
- 2025-12-11
- NPI record certified
- 2025-12-11
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 757 Westwood Plz, Los Angeles, CA, 90095